After completing his economics degree, Peter worked for over 14 years for DAX concerns in many management positions focusing on corporate finance, capital markets, M&A and IR. From 2002 onwards, he served as CFO/ COO for medium size companies including an antibody company in the Biotech sector. Most of these companies are public listed.
Peter serves on the board of a number of companies and personally invests in start-ups.
He is the co- founder and MD of medifundo GmbH & Co. KG.